Thank you, Mr. Rota.
India has increased its manufacturing capacity. It is a very large country. It can lay on new assembly lines and it has done so. As India comes under the patent regime, I agree that this is a challenge. But India is best placed to solve it, because India, remember, also has a CAMR type of law. If conceptually a compulsory licensing law can help, it stands to reason that it will help in the country that is already best practised at making these medicines for export and does so at a lower price.
There's also—